SCHEMBL7722292

SCHEMBL7722292

COC(=O)[C@@H]1CC(N)CN1C(=O)CN(C)C(=O)OC(C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 4/20 0.52
MMP2 P08253 3/20 0.52
ALDH1A1 P00352 1/20 0.33
PEPD P12955 2/20 0.32
XPNPEP1 Q9NQW7 1/20 0.32
CTSD P07339 1/20 0.30
CTSL P07711 1/20 0.30
CTSB P07858 1/20 0.30
CTSS P25774 1/20 0.30
FKBP1A P62942 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7722294 1.00 ANPEP (0.52) ANPEPMMP2ALDH1A1PEPDXPNPEP1
SCHEMBL7731141 0.89 ALDH1A1 (0.43) ANPEPMMP2ALDH1A1PEPDCTSD
SCHEMBL7731145 0.89 ALDH1A1 (0.43) ANPEPMMP2ALDH1A1PEPDCTSD
SCHEMBL7722109 0.83 BTK (0.38) ANPEPMMP2ALDH1A1
SCHEMBL7722111 0.83 BTK (0.38) ANPEPMMP2ALDH1A1
SCHEMBL7726099 0.81 MMP2 (0.42) ANPEPMMP2ALDH1A1
SCHEMBL7726102 0.81 MMP2 (0.42) ANPEPMMP2ALDH1A1
SCHEMBL7722114 0.79 MMP2 (0.30) ANPEPMMP2
SCHEMBL25181712 0.78 ANPEP (0.65) ANPEPMMP2ALDH1A1PEPDXPNPEP1
SCHEMBL670494 0.78 ANPEP (0.65) ANPEPMMP2ALDH1A1PEPDXPNPEP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed
WO-2000001714-A1 EFFLUX PUMP INHIBITORS MICROCIDE PHARMACEUTICALS, INC. (US) 2000-01-13 WO disclosed